Medtronic Stock News

Friday was a rough day on the markets after a new COVID variant spooked investors, sending the Dow Jones down more than 900 points to its worst day of the year. But with the selloff come opportunities for investors to buy some quality stocks on the dip. One healthcare stock to consider is medical device maker Medtronic (NYSE:MDT). Its shares are now trading around 52-week lows as investors worry that a lack of a recovery in the healthcare industry could impact the number of hospital procedures, and thus, demand for Medtronic''s devices. However, the company is still in solid shape. Medtronic released its most recent quarterly results on Nov. 23, reporting sales of $7.8 billion for the period ending Oct. 29. Even though the company says it was negatively impacted by COVID-19 its sales still managed to rise 3% year over year. For longer term investors, it could make for a great recovery stock; CEO Geoff Martha calls the business, one of the best positioned companies in healthcare as it launched new products to help fuel its growth.

Medtronic recently reported its Q2 FY22 results, which were mixed with revenue slightly below, and earnings above our estimates. The company reported sales of around $7.8

The "United Kingdom m-Health App Market Forecasts from 2021 to 2026" report has been added to ResearchAndMarkets.com''s offering. The United Kingdom m-Health app market is projected to grow at a CA

DUBLIN--(BUSINESS WIRE)--The "United Kingdom m-Health App Market - Forecasts from 2021 to 2026" report has been added to ResearchAndMarkets.com''s offering. The United Kingdom m-Health app market is projected to grow at a CAGR of 22.43% to reach US$1,111.589 million by 2026 from US$269.568 million in 2019. Mobile healthcare applications are essentially designed for smartphones, tablets, and even smartwatches. It allows users to track their health and access information whenever they require it.

The global Prosthetic Graft market size is projected to reach a CAGR of 6.2% during 2021-2027. A prosthetic graft is a tubular structure of polyester material that is being used to fix or replace a blood. It has no hazardous

Transcatheter Aortic Valve Replacement Market is projected to boom at a CAGR +12% by the timeline of 2021-28. Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure to replace a narrowed aortic valve that fails to open properly (aortic valve

Major market companies are concentrating on product releases to enhance their position in the global orthopedic power tools market. For instance, Stryker Corporation, a medical device manufacturer, released system 8 power tools with greater capacity battery cells and EZout powered

Implantable neurostimulation devices are used to modulate the nervous system in order to improve biological functions. The activity involves the modulation of electrical signals transferred from the brain to various organs and vice versa. The devices either function by stimulating

Medtronic recently reported its Q2 FY22 results, which were mixed with revenue slightly below, and earnings above our estimates. The company reported sales of around $7.8 billion (up 3% y-o-y), compar

Insight Folios Inc increased its stake in shares of Medtronic plc (NYSE:MDT) by 13.6% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,232 shares of the medical technology companys stock after purchasing an additional 267 shares during the quarter. []

Canvas Wealth Advisors LLC lowered its position in shares of Medtronic plc (NYSE:MDT) by 6.5% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,084 shares of the medical technology companys stock after selling 144 shares during the period. Canvas Wealth Advisors []

Cutler Investment Counsel LLC reduced its holdings in shares of Medtronic plc (NYSE:MDT) by 5.9% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 75,889 shares of the medical technology companys stock after selling 4,763 shares during the period. Medtronic accounts for 1.5% of Cutler Investment Counsel LLCs portfolio, making the stock its 26th []

Zacks Investment Research upgraded shares of Medtronic (NYSE:MDT) from a sell rating to a hold rating in a research note issued to investors on Friday, Zacks.com reports. Zacks Investment Research currently has $121.00 price target on the medical technology companys stock. According to Zacks, Medtronics second-quarter fiscal 2022 earnings beat the Zacks Consensus Estimate while []

Medtronic plc (NYSE:MDT) Analysts at Jefferies Financial Group cut their Q3 2022 earnings per share estimates for Medtronic in a research note issued on Tuesday, November 23rd. Jefferies Financial Group analyst A. Petrone now expects that the medical technology company will post earnings per share of $1.38 for the quarter, down from their prior []

Medtronic plc (NYSE:MDT) Equities researchers at Truist Securiti reduced their Q3 2022 EPS estimates for shares of Medtronic in a research note issued on Tuesday, November 23rd. Truist Securiti analyst D. Rescott now forecasts that the medical technology company will post earnings of $1.38 per share for the quarter, down from their previous forecast []